| Patents for C07J 53 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms (1,809) |
|---|
| 02/05/1997 | CN1033948C Application of dihydrospraketene in preparation of medicinal composition |
| 01/21/1997 | US5595985 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 01/08/1997 | CN1033753C Process for the preparation of 11 beta-phenyl-gonanes |
| 12/19/1996 | WO1996040727A1 Novel nor-pregnanes for inducing hypothalamic effects |
| 12/17/1996 | US5585482 Preparation of 11-keto steroids |
| 12/17/1996 | US5585405 Administering androgen or estrogen inhibitors |
| 12/11/1996 | EP0642529B1 11beta-substituted 14,17-ethanoestratrienes, process for preparing these compounds and their use for preparing medicaments |
| 12/04/1996 | CN1033456C Separation-extraction technology of cyclovirobuxine |
| 11/13/1996 | CN1135488A Application of 19,11 beta-bridged sterodal compound in pharmaceutical working |
| 10/31/1996 | DE19516325A1 High yield prodn. of new or known 14(15)-unsatd. 17alpha-substd. steroid cpds. |
| 10/29/1996 | US5569652 For treatment of menopause disorders; oral contraceptives |
| 10/16/1996 | CN1033033C 19, 11 beta-bridged steroids with progestone anti-activity preparation method |
| 10/08/1996 | US5563131 Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 09/26/1996 | WO1996029068A2 Use of betulinic acid and its derivatives for inhibiting malignant melanoma growth and a method of monitoring this |
| 09/06/1996 | WO1996020209A3 14α,17α-C2-BRIDGED 19-NOR-PROGESTERONE DERIVATIVES |
| 09/04/1996 | CN1130350A Dermatologic preparation |
| 09/03/1996 | US5552393 Method of treating metabolic bone diseases with 21-norvitamin D compounds |
| 08/29/1996 | WO1996026201A1 Benzopyran-containing compounds and method for their use |
| 08/22/1996 | WO1996025512A1 Microorganism of genus chrysosporium for use in preparing farnesyl transferase inhibitors |
| 08/22/1996 | CA2211167A1 Microorganism of genus chrysosporium for use in preparing farnesyl transferase inhibitors |
| 07/04/1996 | WO1996020209A2 14α,17α-C2-BRIDGED 19-NOR-PROGESTERONE DERIVATIVES |
| 07/04/1996 | DE4447401A1 14,17-C¶2¶-überbrückte Steroide 14,17-bridged C¶2¶-steroids |
| 06/26/1996 | EP0717985A1 Dermatologic preparation |
| 06/26/1996 | EP0717983A1 Cosmetic compositions containing betulinic acid |
| 06/25/1996 | US5529993 Urogenital disorders; contraceptives |
| 06/25/1996 | US5529769 Cosmetic compositions containing betulinic acid |
| 06/04/1996 | US5523427 Medrogestone production |
| 06/04/1996 | US5523298 Used to induce labor, abortion, menstruation, and againsts hormonal irregularities |
| 05/29/1996 | EP0713880A2 Stereoselective reduction of 17-ketosteroids |
| 05/21/1996 | US5519153 Multistage reaction with oxidation, dehydration, isolation and hydrolysis |
| 04/24/1996 | EP0707593A1 Orally administerable esters of 14 alpha,15 alpha-methylene-oestradiol with an oestrogenic action |
| 04/23/1996 | US5510340 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
| 04/04/1996 | WO1996010032A1 Novel estrenes for inducing hypothalamic effects |
| 04/04/1996 | CA2199044A1 Novel estrenes for inducing hypothalamic effects |
| 03/26/1996 | US5502046 11β-substituted 14,17-ethanoestratrienes, process for their production and their use as pharmaceutical agents |
| 03/21/1996 | WO1996008505A1 Steroid esters and amides, method for their preparation and their pharmaceutical use |
| 03/21/1996 | DE4434488A1 Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung Steroid esters and amides, process for their preparation and their pharmaceutical use |
| 02/22/1996 | WO1996005217A1 Pharmaceutical compositions containing estra-1,3,5(10)-triene derivatives |
| 02/22/1996 | WO1996005216A1 Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceutical compositions containing them |
| 02/22/1996 | CA2196694A1 Estra-1,3,5(10)-triene derivatives, process of preparing such compounds and pharmaceutical compositions containing them |
| 02/22/1996 | CA2196678A1 Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives |
| 02/21/1996 | CN1117050A 14 alpha, 17 alpha-ethano-16 alpha-hydroxy-estratriene |
| 02/21/1996 | CN1031061C Process for preparing of 14 alpha, 17 alpha-ethano-16 alph-hydroxy-estratriene derivatives |
| 02/15/1996 | WO1996004296A1 Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function |
| 02/15/1996 | DE4429398A1 Pharmazeutische Zusammensetzungen mit Estra-1,3,5(10)-trien-Derivaten Pharmaceutical compositions with Estra-1,3,5 (10) -triene derivatives |
| 02/15/1996 | DE4429397A1 Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Estra-1,3,5 (10) -triene derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 02/13/1996 | US5491137 Treating estrogen deficiency |
| 01/25/1996 | WO1996001618A1 Dermatologic preparation |
| 01/04/1996 | WO1996000235A1 Sterol derivatives used for regulation of meiosis |
| 12/26/1995 | US5478956 8-En-19 11 β-bridged steroids, their production and pharmaceutical preparations containing them |
| 11/23/1995 | WO1995031471A1 19,11β BRIDGED 18-NOR STEROIDS, PROCESS FOR PRODUCING THEM, MEDICAMENTS CONTAINING SAID STEROIDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS |
| 11/23/1995 | DE4417880A1 19,11beta-Überbrückte 18-Nor-Steroide, Verfahren zu ihrer Herstellung, diese Steroide enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln 19,11beta Bridged-18-nor-steroids, processes for their preparation, pharmaceutical compositions containing these steroids and their use for the preparation of medicaments |
| 11/08/1995 | EP0680970A2 Medrogestrone |
| 11/06/1995 | CA2148525A1 Medrogestone production |
| 10/19/1995 | WO1995027726A1 10,11-c3-bridged steroids |
| 10/19/1995 | WO1995027725A1 11β,19-BRIDGED 13α-ALKYL STEROIDS |
| 10/19/1995 | DE4413185A1 11beta,19-überbrückte 13alpha-Alkylsteroide 11beta, 13alpha-19-bridged Alkylsteroide |
| 10/19/1995 | DE4413184A1 10,11-C¶3¶-überbrückte Steroide 10,11-bridged C¶3¶-steroids |
| 09/06/1995 | CN1029683C Process for preparing new steroids substituted at position 10 by a radical including a double or triple bond |
| 08/29/1995 | US5446178 Process for preparing 19,11β-bridged steroids |
| 08/22/1995 | US5443829 For enhancing delivery of drugs across mucous membranes of animals |
| 08/08/1995 | US5439913 Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| 08/08/1995 | US5439902 14α, 16α-ethanoand 14α, 16α-etheno-estratrienes |
| 08/08/1995 | US5439901 Cyproterone thiopivalate |
| 08/02/1995 | EP0664811A1 Gestagenically active 19,11-bridged 4-estrenes. |
| 07/06/1995 | WO1995018142A1 Wf15604 substances |
| 06/28/1995 | EP0377743B1 Steroid compounds |
| 06/27/1995 | US5428151 Medrogestrone production |
| 06/21/1995 | EP0658111A1 Methods for enhancing drug delivery with modified saponins |
| 06/20/1995 | US5426179 Substituted androstanes |
| 06/15/1995 | WO1995015943A1 21-norvitamin d compounds |
| 06/13/1995 | US5424462 Method for producing (+)-estrone derivatives |
| 05/24/1995 | CN1102830A Oral estrin active ester of 14 alpha, 15 alpha-methylen-estradiol |
| 05/23/1995 | US5418227 For treatment of estrogen deficiency symptoms |
| 05/04/1995 | WO1995011915A1 10,11β-C2-BRIDGED STEROIDS |
| 04/18/1995 | US5407928 Progesterone antagonist suitable for inducing labor or an abortion |
| 03/29/1995 | EP0644891A1 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
| 03/15/1995 | EP0642529A1 11-g(b)-SUBSTITUTED 14,17-ETHANOESTRATRIENES, PROCESS FOR PREPARING THESE COMPOUNDS AND THEIR USE FOR PREPARING MEDICAMENTS. |
| 03/07/1995 | US5395842 Inhibitors of sex steroids |
| 03/01/1995 | EP0639970A1 Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| 02/28/1995 | US5393785 Therapeutic antiestrogens |
| 02/28/1995 | CA1334587C Steroid compounds |
| 02/22/1995 | EP0639201A1 14,16beta-ETHANO-15beta,16' -CYCLO-14beta-ESTRA-1,3,5(10)-TRIENES |
| 02/02/1995 | WO1995003320A1 Cyproterone thiopivalate |
| 02/02/1995 | WO1995003319A1 Cyproterone acetate thioacetate |
| 01/24/1995 | US5384313 21-norvitamin D compounds |
| 01/19/1995 | WO1995001988A1 ORALLY ADMINISTERABLE ESTERS OF 14α,15α-METHYLENE-OESTRADIOL WITH AN OESTROGENIC ACTION |
| 01/04/1995 | CN1027270C 14,17 beta-ehano-14 beta-estratrienes and estratetranenes, process for their production and pharmaceutical preparations containing them |
| 12/13/1994 | US5372996 Method of treatment of androgen-related diseases |
| 11/15/1994 | US5364847 Inhibitors of sex steroid biosynthesis and methods for their production and use |
| 10/26/1994 | EP0620823A1 6,7$g(a)-DIFLUOROMETHYLENANDROSTA-1,4-DIEN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION |
| 10/19/1994 | EP0619952A1 Food additive and use thereof |
| 09/21/1994 | EP0615448A1 Sex steroid activity inhibitors |
| 09/21/1994 | CN1092428A Conception promoting 19, 11beta-overbrige 4-estratrene |
| 09/06/1994 | US5344651 Cyproterone acetate thioacetate |
| 08/25/1994 | DE4305730A1 14,17- alpha -etheno- and -ethanoestra-1,3,5(10),6-tetraenes, -1,3,5(10),6,8(9)-pentaenes and -1,3,5(10),6,8(9),11-hexaenes, processes for their preparation, pharmaceutical products which contain these compounds, and the use thereof for producing medicines |
| 06/22/1994 | EP0602123A1 Steroid sulphatase inhibitors |
| 06/16/1994 | DE4235220A1 Gestagen wirksame 19,11ß-überbrückte 4-Estrene Progestin effective 19,11ß-bridged 4-Estrenes |
| 06/08/1994 | CN1087643A Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| 06/01/1994 | DE4239946A1 Prepn. of new and known 14alpha,15alpha-methylene-estrane derivs. - useful as anti-fertility agents, from 3-alkoxy-estra-1,3,5(10),8,14-pentaen-17alpha-ol by methylenation, oxidn., redn. |